Patient decision aids (PtDA) are tools that medical providers use as a supplement to the clinical discussion.
These decision aids aim to present rheumatoid arthritis (RA) medications in a clear, accurate, and balanced way. They walk the reader through a decision so you know more about facts and pause to think about what matters most. If you work through the decision aid on the medication you are most seriously considering you should be well prepared to make a informed decision with your doctor.
We have developed and used these PtDA with hundreds of RA patients considering new anti-rheumatic therapies.
The decision aids use plain language, express outcome probabilities in multiple ways and were developed following International Patient Decision Aid Standards Consortium criteria. Our testing suggests that the PtDAs are acceptable to patients and effectively inform them of the risks and benefits of DMARDs.
The use of PtDA is an important strategy to support doctor - patient dialogues and to encourage shared decision making.
Begin by watching the introductory video below.
Then select the decision aid you want to explore in more detail.